Results 151 to 160 of about 588,781 (167)

Postmarketing surveillance of safety and effectiveness of etanercept in Japanese patients with rheumatoid arthritis

Modern Rheumatology, 2011
Yoshiya Tanaka, Masayoshi Harigai, Tsutomu Takeuchi   +2 more
exaly   +2 more sources

Safety and effectiveness of adalimumab in Japanese rheumatoid arthritis patients: postmarketing surveillance report of the first 3,000 patients

Modern Rheumatology, 2012
Hisashi Yamanaka, Yoshiya Tanaka, Masayoshi Harigai   +2 more
exaly   +2 more sources

Effectiveness of drug postmarketing all-case surveillance as a safety measure in Japan

Therapeutic Advances in Drug Safety, 2021
Ken Masamune, Hideyuki Kondo
exaly  

Postmarketing surveillance for drug abuse

Drug and Alcohol Dependence, 2003
Theodore Cicero, Cynthia Arfken
exaly  

Safety and effectiveness of adalimumab in Japanese rheumatoid arthritis patients: Postmarketing surveillance report of 7740 patients

Modern Rheumatology, 2014
Hisashi Yamanaka, Yoshiya Tanaka, Tsutomu Takeuchi   +2 more
exaly  

Postmarketing surveillance evaluating the safety and effectiveness of golimumab in Japanese patients with rheumatoid arthritis

Modern Rheumatology, 2018
Atsushi Kawakami, Shigeki Momohara
exaly  

Sample Size and Postmarketing Surveillance

Drug Information Journal, 1985
Fred Schneiweiss
exaly  

Safety and effectiveness of iguratimod in patients with rheumatoid arthritis: Final report of a 52-week, multicenter postmarketing surveillance study

Modern Rheumatology, 2019
Tatsuya Atsumi, Takao Fujii, Tsuneyo Mimori   +2 more
exaly  

Efficacy and safety of garenoxacin tablets on bacterial pneumonia: Postmarketing surveillance in Japan

Journal of Infection and Chemotherapy, 2014
Tadashi Ishida, Koichi Izumikawa, Naoyuki Miyashita   +2 more
exaly  

Detecting Adverse Drug Reactions in Postmarketing Surveillance: Interview Validity

Drug Information Journal, 1987
Seymour Fisher
exaly